Atlas Trials

Open Label Study to Assess Safety, PK and Explore Efficacy of OPRX-106 in Patients With Active Mild to Moderate Ulcerative Colitis

Clinical trial NCT02768974 · UNKNOWN

Trial details

NCT number
NCT02768974
Sponsor
Protalix
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2016-09-01
Primary completion
2017-02-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.